← Back to Search

Imaging Device

Optical coherence tomography angiography for Diabetic Retinopathy

N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
No Placebo-Only Group

Summary

This trial uses advanced imaging tools to take detailed pictures of the tiny blood vessels in the eyes of people with diabetes. It focuses on patients with different levels of diabetic retinopathy, a common complication that can impair vision. The imaging techniques use light waves to capture detailed images, helping doctors see changes that aren't visible with regular eye exams.

Eligible Conditions
  • Diabetic Retinopathy
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Perfusion density
Secondary study objectives
Areas of different perfusion density
Change in perfusion density in patients with moderate or severe non proliferative diabetic retinopathy (DR) or low risk proliferative DR over the follow up of one year
Foveal avascular zone (FAZ)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: OCTAExperimental Treatment1 Intervention
Patients with diabetes and healthy controls will be imaged with optical coherence tomography (OCT) angiography, Spectral domain OCT and ultra wide-field imaging.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Optical coherence tomography angiography
2017
N/A
~420

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,485,322 Total Patients Enrolled
4 Trials studying Diabetic Retinopathy
38 Patients Enrolled for Diabetic Retinopathy
~25 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top